Use of Preventive Measures for Cardiovascular Disease in People With HIV.

ABSTRACT:

Background

Data on uptake of preventive measures for cardiovascular disease (CVD) in people with HIV are limited.

Methods

We determined the annual prevalence (2012-2021) of CVD preventive measures use for RESPOND participants with a very high (>10%) estimated D:A:D 10-year CVD risk who were eligible for each specific measure evaluated. We used binomial regression to assess factors associated with each preventative measure uptake.

Results

Between 2012 and 2021, the crude proportion of >10% estimated 10-year CVD risk individuals increased from 32.4% (n = 4272) to 52.1% (n = 5298). At the end of follow-up, among very high-risk individuals, 67.4% (1552/2303) with hypertension used antihypertensives, 55.9% (1562/2792) with dyslipidemia lipid-lowering drugs (LLDs), and 7.4%

SUBMITTER: Jaschinski N 

PROVIDER: S-EPMC12569598 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature